Abstract
Dysregulation of the inflammatory response system has been linked to pathophysiology of schizophrenia.1,2 Evidence of immune activation has derived from the detection of abnormal levels of proinflammatory cytokines and their receptors in peripheral blood and cerebrospinal fluid from schizophrenic patients.3–7 Cytokines are involved in normal CNS development as well as in the pathogenesis of many neuro-psychiatric disorders, acting directly on neural cells or modulating neurotransmitter and neuropeptide systems.8,9 In particular tumor necrosis factor α (TNFα), depending on its concentration, can exert both neurotrophic and neurotoxic effects and influence neural cell growth and proliferation.10,11 Moreover, TNFα gene is located on the small arm of chromosome 6 (6p21.1–21.3), a locus associated with genetic susceptibility to schizophrenia.12,13 We studied the distribution of −G308A TNFα gene polymorphism in 84 schizophrenic patients and in 138 healthy volunteers. This biallelic base exchange polymorphism directly affects TNFα plasma levels.14–18 Frequency of the TNF2(A) allele is significantly increased in schizophrenic patients as compared to controls (P = 0.0042). Genotype distribution is also significantly different (P = 0.0024). TNF2 homozygotes are represented only in the patient group (P = 0.002). These data suggest a potential role of TNFα as a candidate gene for susceptibility to schizophrenia and suggest that immune dysregulation in schizophrenic patients could also have a genetic component.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Muller N, Riedel M, Ackenheil M, Schwarz MJ . The role of immune function in schizophrenia: an overview Eur Arch Psychiatry Clin Neurosci 1999 249 Suppl 4: 62–68
Altamura AC, Boin F, Maes M . HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment Eur Neuropsychopharmacol 1999 10: 1–4
Naudin J, Capo C, Giusano B, Mege JL, Azorin JM . A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr Res 1997 26: 227–233
Monteleone P, Fabrazzo M, Tortorella A, Maj M . Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment Psychiatry Res 1997 71: 11–17
Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura G, Pioli R, Boin F et al. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics Eur Neuropsychopharmacol 2000 10: 119–124
Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY . Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers J Psychiatr Res 1995 29: 141–152
Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH . Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients Am J Psychiatry 1993 150: 1408–1410
Plata-Salaman C, Turrin N . Cytokine interactions and cytokine balance in the brain: relevance to neurology and psychiatry Mol Psychiatry 1999 4: 302–306
Muller N, Ackenheil M . Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 1998 22: 1–33
Rothwell NJ, Hopkins SJ . Cytokines and the nervous system II: Actions and mechanisms of action Trends Neurosci 1995 18: 130–136
Loddick SA, Rothwell NJ . Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1 Proc Natl Acad Sci USA 1999 96: 9449–9451
Maier W, Schwab S, Rietschel M . The genetics of schizophrenia Curr Opin Psychiatry 2000 13: 3–9
Peltonen L . Schizophrenia: all out for chromosome six Nature 1995 378: 665–666
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW . Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proc Natl Acad Sci USA 1997 94: 3195–3199
Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT . Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis Gastroenterology 1999 117: 645–652
Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study JAMA 1999 282: 561–568
Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria Nat Genet 1999 22: 145–150
Li Kam Wa TC, Mansur AH, Britton J, Williams G, Pavord I, Richards K et al. Association between −308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma Clin Exp Allergy 1999 29: 1204–1208
Katila H, Hanninen K, Hurme M . Polymorphisms of the interleukin-1 gene complex in schizophrenia Mol Psychiatry 1999 4: 179–181
Licinio J, Wong ML . Pathways and mechanisms for cytokine signaling of the central nervous system J Clin Invest 1997 100: 2941–2947
Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schuld A et al. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis J Psychiatr Res 1999 33: 407–418
Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY . In vivo immunomodulatory effects of clozapine in schizophrenia Schizophr Res 1997 26: 221–225
Pollmacher T, Hinze-Selch D, Mullington J . Effects of clozapine on plasma cytokine and soluble cytokine receptor levels J Clin Psychopharmacol 1996 16: 403–409
Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression J Affect Disord 1995 34: 301–309
Bauer J, Ganter U, Strauss S, Stadtmuller G, Frommberger U, Bauer H et al. The participation of interleukin-6 in the pathogenesis of Alzheimer's disease Res Immunol 1992 143: 650–657
Brambilla F, Bellodi L, Perna G, Bertani A, Panerai A, Sacerdote P . Plasma interleukin-1 beta concentrations in panic disorder Psychiatry Res 1994 54: 135–142
Brambilla F, Perna G, Bellodi L, Arancio C, Bertani A, Perini G et al. Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders Biol Psychiatry 1997 42: 976–981
Gupta S, Aggarwal S, Rashanravan B, Lee T . Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism J Neuroimmunol 1998 85: 106–109
Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety Cytokine 1998 10: 313–318
McGuffin P, Owen MJ, Farmer AE . Genetic basis of schizophrenia Lancet 1995 346: 678–682
O'Donovan MC, Owen MJ . Candidate-gene association studies of schizophrenia Am J Hum Genet 1999 65: 587–592
Malinin NL, Boldin MP, Kovalenko AV, Wallach D . MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1 Nature 1997 385: 540–544
Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus Arthritis Rheum 2000 43: 129–134
Wilson AG, di Giovine FS, Blakemore AI, Duff GW . Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product Hum Mol Genet 1992 1: 353
Yolken RH, Torrey EF . Viruses, schizophrenia, and bipolar disorder Clin Microbiol Rev 1995 8: 131–145
Beckmann H . Developmental malformations in cerebral structures of schizophrenic patients Eur Arch Psychiatry Clin Neurosci 1999 249 Suppl 4: 44–47
First MB, Spitser RL, Williams JBW, Gibbon M . Structured Clinical Interview for DSM-IV – Patient Edition (SCID-P) American Psychiatric Press: Washington, DC 1995
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16: 1215
Acknowledgements
This research was supported by a grant from the Italian Ministry of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boin, F., Zanardini, R., Pioli, R. et al. Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 6, 79–82 (2001). https://doi.org/10.1038/sj.mp.4000815
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000815
Keywords
This article is cited by
-
Overexpression of transmembrane TNFα in brain endothelial cells induces schizophrenia-relevant behaviors
Molecular Psychiatry (2023)
-
Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
BMC Psychiatry (2021)
-
Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia
Journal of Neuroinflammation (2016)
-
DNA methylation differences in monozygotic twin pairs discordant for schizophrenia identifies psychosis related genes and networks
BMC Medical Genomics (2015)
-
Evaluating historical candidate genes for schizophrenia
Molecular Psychiatry (2015)